Project dates: September 2012 – March 2017
SIAPS Central Asia End of Project Report
Archive Uzbekistan
Initiation of the Pilot on Implementation of the Early Warning and Quantification System for Anti-TB Medicines in Uzbekistan
A comprehensive indicator-based assessment of the tuberculosis (TB) in pharmaceutical management system, which was conducted with SIAPS assistance in July-August of 2014, revealed crucial needs for strengthening the anti-TB medicines supply system in Uzbekistan through improved supply planning and implementation of an early warning mechanism in order to avoid problems with stocks-outs and expiration of … Read more
SIAPS Speakers Present at 2015 Global Health Mini-University
Three members of the SIAPS team presented at the 2015 Global Health Mini-University, held on Monday, March 2, at the George Washington University’s Cloyd Heck Marvin Center in Washington, DC. SIAPS Technical Associate Shirin Kakayeva presented on multidrug-resistant tuberculosis (MDR-TB) in Central Asia, highlighting the high MDR-TB burden in Tajikistan (13%) and Uzbekistan (23%) in particular. Kakayeva discussed the … Read more
Strengthening the TB pharmaceutical management system and ensuring patients’ uninterrupted access to anti-TB medicines in Uzbekistan
By Shirin Kakayeva, SIAPS Technical Associate and Dr. Archil Salakaia, SIAPS Central Asia Portfolio Manager Uzbekistan is one of 18 high-priority countries in the WHO’s European region, and is among 27 high-burden multidrug-resistant tuberculosis (MDR-TB) countries in the world. As the uninterrupted supply of anti-TB medicines is necessary for the survival of TB patients, pharmaceutical management … Read more
